BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22846976)

  • 21. [Vena cava superior syndrome in total parenteral nutrition. Vena cava superior thrombosis caused by a central venous catheter].
    Svane S
    Tidsskr Nor Laegeforen; 1990 Mar; 110(7):840-2. PubMed ID: 2108513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bypass of superior vena cava. Fifteen years' experience with spiral vein graft for obstruction of superior vena cava caused by benign disease.
    Doty DB; Doty JR; Jones KW
    J Thorac Cardiovasc Surg; 1990 May; 99(5):889-95; discussion 895-6. PubMed ID: 2329828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombosis of the superior vena cava and auxiliary branches in patients with indwelling catheterization of the internal jugular vein.
    Li H; Wang SX; Wang W; Xu C; Shen S; Yu L; Zhang GZ
    Chin Med J (Engl); 2009 Mar; 122(6):692-6. PubMed ID: 19323936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of superior vena cava syndrome due to extensive venous thrombosis of an idiopathic nature].
    Suzuki J; Kanbayashi T; Koizumi T; Honda T; Yamada H; Sekiguchi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1761-5. PubMed ID: 1447855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary to saphenous vein bypass for treatment of central venous obstruction in patients receiving dialysis.
    Kavallieratos N; Kokkinos A; Kalocheretis P
    J Vasc Surg; 2004 Oct; 40(4):640-3. PubMed ID: 15472589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Feasibility of peripheral vein during FOLFOX/FOLFIRI chemotherapy through peripheral venous system].
    Kimura T; Iwase K; Aono T; Nakai S; Fujii M; Nishikawa K; Matsuda C; Shimada K; Hirota M; Nasu S; Wada D; Hasegawa J; Tanaka Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1889-94. PubMed ID: 19011337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mediastinal large B-cell lymphoma with symptomatic superior vena cava syndrome in a patient with bichorial twin pregnancy in the 26th week of gestation: peri-and postpartal management -- a case report].
    Djakovic A; Ott G; Zollner U; Vordermark D; Dietl J
    Zentralbl Gynakol; 2005 Aug; 127(4):248-51. PubMed ID: 16037907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Benefits of totally implanted central venous access in patients with cancer].
    Saito H; Kamada T; Sakurai Y; Hanawa M; Takamura A
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):519-24. PubMed ID: 1558403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantable venous access device associated complications in patients with hereditary angioedema.
    Yoo SM; Khan DA
    J Allergy Clin Immunol Pract; 2013; 1(5):524-5. PubMed ID: 24565628
    [No Abstract]   [Full Text] [Related]  

  • 32. How to perform extracorporeal photopheresis via port catheter.
    Schwede K; Nagel S; Simon JC; Ziemer M
    Transfusion; 2017 Nov; 57(11):2567-2570. PubMed ID: 28782257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Access of a fully rotated implantable port leads to extravasation.
    Goossens GA; Kerschaever I; Despierre E; Stas M
    J Vasc Access; 2013; 14(3):299-300. PubMed ID: 23543490
    [No Abstract]   [Full Text] [Related]  

  • 34. Complete caval thrombosis secondary to an implanted venous port--a case study.
    Hasskarl J; Köberich S; Frydrychowicz A; Illerhaus G; Waller CF
    Dtsch Arztebl Int; 2008 Jan; 105(1-2):18-21. PubMed ID: 19578449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy Port Induced SVC Thrombosis in a Patient with Non-metastatic Breast Cancer.
    Kania B; Mekheal E; Ghrewati M; Mekheal N; Koj J; Farokhian A; Maroules M
    J Community Hosp Intern Med Perspect; 2022; 12(4):66-69. PubMed ID: 36262890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous placement of an implantable arm port through an internal mammary venous pathway: Case report.
    Urbania T; Hershock DM; Clark TW
    J Vasc Access; 2003; 4(4):154-7. PubMed ID: 17639495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Femoral Access for Central Venous Port System Implantation.
    Cherkashin M; Berezina N; Puchkov D; Suprun K; Yablonsky P
    Cureus; 2018 Mar; 10(3):e2327. PubMed ID: 29765794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bevacizumab and Glioblastoma Multiforme: A Thrombosis and Bleeding Dilemma (A Case Report and a Brief Review of the Literature).
    Patel D; Salkeni M; Chaudhary R
    Am J Ther; 2013 Apr; ():. PubMed ID: 23584310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Totally implantable venous access system (TIVAS) Complicated by Tracheo-Venous Fistula.
    Khaled S; Gotlieb V; Patel A
    Radiol Case Rep; 2009; 4(1):266. PubMed ID: 27843525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of chemotherapy treatment administration via venous port and peripheral vascular access in terms of quality of life and costs.
    Erişen MA; Yılmaz FÖ
    Qual Life Res; 2023 Jul; 32(7):1897-1908. PubMed ID: 36790666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.